Recent advances of nanodrug delivery system in the treatment of hematologic malignancies
Q Ye, Y Lin, R Li, H Wang, C Dong - Seminars in cancer biology, 2022 - Elsevier
Although the survival rate of hematological malignancies (HM) has increased in recent
years, the unnecessary adverse effect to the body is usually generated by the traditional …
years, the unnecessary adverse effect to the body is usually generated by the traditional …
Recent advances of nanodrug delivery system in the treatment of hematologic malignancies.
Q Ye, Y Lin, R Li, H Wang, C Dong - Seminars in Cancer Biology, 2022 - europepmc.org
Although the survival rate of hematological malignancies (HM) has increased in recent
years, the unnecessary adverse effect to the body is usually generated by the traditional …
years, the unnecessary adverse effect to the body is usually generated by the traditional …
Recent advances of nanodrug delivery system in the treatment of hematologic malignancies
Q Ye, Y Lin, R Li, H Wang… - Seminars in cancer …, 2022 - pubmed.ncbi.nlm.nih.gov
Although the survival rate of hematological malignancies (HM) has increased in recent
years, the unnecessary adverse effect to the body is usually generated by the traditional …
years, the unnecessary adverse effect to the body is usually generated by the traditional …